[ad_1] RT @ThomasCiullaMD: Excited to present on #suprachoroidal drug delivery at @OphthalmologyFF! After FDA approval of #Xipere, SC delivery be… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] RT @ThomasCiullaMD: Now in print, in this month’s British Journal of Ophthalmology: Extension study of the safety and efficacy of CLS-TA fo… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
RT @ThomasCiullaMD: Dr Steven Yeh on Patients Treated With Xipere and Its Use Over the Long Term https://t.co/nWhm7CUCJP via @AJMC_Journal
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Excited to present on #suprachoroidal drug delivery at @OphthalmologyFF! After FDA approval of #Xipere, SC delivery became a reality. Now, #clinicaltrials involving SC delivery include a TKI, a steroid, a #genetherapy & a virus-like drug conjugate. #eyes https://t.co/SyafhDOM7l https://t.co/J7G54DeoOw [ad_2] Source by Thomas Ciulla, …
[ad_1] RT @RetinalPhys: Video in this article shows Dennis Marcus, MD, administering suprachoroidal RGX-314 in a patient with diabetic retinopathy… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
Now in print, in this month’s British Journal of Ophthalmology: Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA) https://t.co/jnWs2e0xOj
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] RT @ThomasCiullaMD: Just published @RetinalPhys: #Suprachoroidal Drug Delivery Technology. After #Xipere’s approval, SC #drugdelivery is cl… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] RT @ThomasCiullaMD: It means a lot to be recognized by colleagues. I am honored to be named a “2022 Top Doctor”. Very grateful to work wit… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
RT @ThomasCiullaMD: Just published: This post hoc analysis compared #suprachoroidal triamcinolone acetonide (CLS-TA) to other commonly avai…
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] RT @ThomasCiullaMD: National physician survey on clinical practice patterns for the treatment of noninfectious uveitis | IOVS | ARVO Journa… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.